for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

OTSUKA CORPORATION

4768.T

Latest Trade

4,485.00JPY

Change

75.00(+1.70%)

Volume

697,500

Today's Range

4,435.00

 - 

4,510.00

52 Week Range

2,783.00

 - 

4,580.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
4,410.00
Open
4,440.00
Volume
697,500
3M AVG Volume
9.14
Today's High
4,510.00
Today's Low
4,435.00
52 Week High
4,580.00
52 Week Low
2,783.00
Shares Out (MIL)
189.60
Market Cap (MIL)
837,909.40
Forward P/E
20.72
Dividend (Yield %)
1.93

Next Event

Dividend For 4768.T - 95.0000 JPY

Latest Developments

More

Verily Forms Strategic Alliances With Novartis, Otsuka, Pfizer And Sanofi To Transform Clinical Research

Otsuka announces results of phase 3 data on tolvaptan

Otsuka's 9-month group operating profit seen at about 28 bln yen - Nikkei

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About OTSUKA CORPORATION

OTSUKA CORPORATION is a Japan-based company mainly engaged in the sale of system equipment, the installation support and maintenance services. The Company operates through two business segments. System Integration segment conducts consulting, hardware and software sales, contract software development, equipment installation and network construction. Service & Support segment provides office supply, maintenance services, as well as business support services. The Company is also involved in the car maintenance business and insurance business.

Industry

Computer Services

Contact Info

Otsuka Shokai Honsha Bldg.

2-18-4, Iidabashi

+81.3.32647111

https://www.otsuka-shokai.co.jp/

Executive Leadership

Yuji Ohtsuka

President, Chief Director of Marketing, Representative Director

Kazuyuki Katakura

Head Senior Managing Executive Officer, Chief Director of Sales, Deputy Chief Director of Marketing, Director

Hironobu Tsurumi

Senior Managing Executive Officer, Deputy Chief Director of Sales, Director of CAD Promotion, Manager of CAD, Director

Toshiyasu Takahashi

Head Senior Managing Executive Officer, Director of Tanomeeru Business, Director of Tanomeeru Information, Director of Tanomeeru Marketing, Director of Logistics Promotion, Director

Norihiko Moriya

Managing Executive Officer, Chief Director of Business Administration, Director of Human Resources Development, Director

Key Stats

2.50 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2016

0.6K

2017

0.7K

2018

0.8K

2019(E)

0.9K
EPS (JPY)

2016

140.690

2017

166.455

2018

177.220

2019(E)

212.849
Price To Earnings (TTM)
19.91
Price To Sales (TTM)
0.97
Price To Book (MRQ)
3.39
Price To Cash Flow (TTM)
16.94
Total Debt To Equity (MRQ)
2.63
LT Debt To Equity (MRQ)
0.69
Return on Investment (TTM)
17.09
Return on Equity (TTM)
10.11

Latest News

Latest News

BRIEF-Otsuka announces results of phase 3 data on tolvaptan

* Says primary and key secondary endpoints were positive for tolvaptan versus placebo in an additional phase 3 clinical trial

Novartis wins U.S. approval for breast cancer drug; to compete with Pfizer's Ibrance

Novartis has won U.S. Food and Drug Administration approval for Kisqali to treat postmenopausal women who have a difficult-to-treat form of breast cancer, challenging U.S. rival Pfizer's Ibrance.

Lundbeck gives up on Alzheimer's drug, rival to Axovant pill

Two remaining late-stage clinical trials testing an experimental Alzheimer's drug from Denmark's Lundbeck have failed, scuppering hopes for the medicine and underscoring the difficulty of developing such treatments.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up